Skip to main content
Home Licenses Page 5

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

AWS Announces General Availability of Amazon Braket

Amazon Braket helps developers and researchers get started with quantum computing, providing development tools, simulators, and access to a diverse set of quantum hardware. Fidelity Investments, Volkswagen, Enel, University of Waterloo, Rahko, and Qu & Co…

Read More

Uplizna launch is a ‘testament’ to NC’s prowess in drug R&D

When singer songwriter Joni Mitchell wrote “…you don’t know what you’ve got ‘til it’s gone,” she didn’t know Thomas F. Tedder, Ph.D. Tedder, the Alter Geller Professor for Research in Immunology at Duke University Medical…

Read More

Working and collaborating with University Technology Transfer Offices

The third podcast of Venture Connect online with partners Wilson Sonsini Goodrich and Rosati: The three great universities that form the vertices of the Triangle of North Carolina are engines of innovation for its ecosystems. Every year these…

Read More

Duke Licensee Genetron Health Prices $256M US IPO

Beijing-based Genetron Health on Friday announced pricing of its previously announced initial public offering of 16,000,000 American Depositary Shares, each representing five ordinary company shares at $16.00 per ADS. The gross proceeds from the initial public offering…

Read More

COVID-19 Licensing Guidelines

The COVID-19 pandemic has rapidly moved the work of technology transfer offices from university and other non-profit research organizations to the battle’s front line. In order to support Membership worldwide and enable a swift end…

Read More

Bloom Science Granted Exclusive Option to License Gut Microbiome-based Therapies for ALS, Other Neurological Disorders

Bloom Science and Duke University have entered into an exclusive licensing agreement that provides the biopharmaceutical company access to the intellectual property and technology related to unique strain isolates and genetic variants of Akkermansia genus bacteria. This type of…

Read More

SeaSpine® Announces Exclusive Development and Licensing Agreement with restor3D®

September 24, 2019 CARLSBAD, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it…

Read More

Immunomic Therapeutics Assumes Sponsorship of ATTAC II IND for a Brain Cancer Vaccine

Immunomic Therapeutics, Inc. announced today that it has assumed sponsorship of the Investigational New Drug (IND) application for ITI-1000 from the University of Florida (UF). ITI-1000 is currently being investigated in a Phase 2 ATTAC-II…

Read More

Exclusive License Agreement for Duke start-up, restor3D®

Ken Gall’s 3D-printing company, restor3D, has signed an exclusive license with SeaSpine, a global medical tech company. SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal…

Read More